Results 201 to 210 of about 13,808 (210)
Some of the next articles are maybe not open access.

ADAMTS13 and Angiogenesis

2015
ADAMTS13 has been identified as the von Willebrand factor-cleaving protease and is deficient in the disorder thrombotic thrombocytopenic purpura. The identification of vascular endothelium as a site of synthesis and secretion of ADAMTS13 has led to studies of the role of ADAMTS13 in angiogenesis.
Manfai Lee, George M. Rodgers
openaire   +1 more source

ADAMTS13

Archives of Surgery, 2012
Delawir Kahn, Jake E. Krige
openaire   +1 more source

ADAMTS13 testing: why bother?

Blood, 2010
In this issue of Blood , Kremer Hovinga and colleagues demonstrate that a lower level of initial plasma ADAMTS13 activity (< 10%) is associated with higher risk of relapse in patients with TTP.
openaire   +2 more sources

ADAMTS13: Structure and Function

2015
ADAMTS13, a plasma metalloprotease that cleaves von Willebrand factor (VWF), has been shown to have both antithrombotic and anti-inflammatory activities. Severe deficiency of plasma ADAMTS13 activity is a primary cause of thrombotic thrombocytopenic purpura (TTP), a potentially fatal syndrome, but mild to moderate deficiency of plasma ADAMTS13 activity
openaire   +1 more source

ADAMTS13

2017
Christian R. Robinson   +2 more
openaire   +1 more source

Measurement of ADAMTS13.

International review of thrombosis
ADAMTS13, encoded on chromosome 9q34, is a member of the ADAMTS (a disintegrin and metalloprotease with thrombospondin type 1 motif) metalloprotease family, containing the common domain structure of (from the amino terminus) signal peptide, propeptide, reprolysin type metalloprotease, thrombospondin type 1 motif, cysteine-rich region, and spacer domain.
openaire   +1 more source

ADAMTS13 endopeptidase 3.4.24.87

2013
Dietmar Schomburg, Ida Schomburg
openaire   +1 more source

Home - About - Disclaimer - Privacy